270 related articles for article (PubMed ID: 35907682)
61. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
[TBL] [Abstract][Full Text] [Related]
62. Pericervical Injection of 99mTc-Nanocolloid Is Superior to Peritumoral Injection for Sentinel Lymph Node Detection of Endometrial Cancer in SPECT/CT.
Sahbai S; Taran FA; Fiz F; Staebler A; Becker S; Solomayer E; Wallwiener D; la Fougère C; Brucker S; Dittmann H
Clin Nucl Med; 2016 Dec; 41(12):927-932. PubMed ID: 27749429
[TBL] [Abstract][Full Text] [Related]
63. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
Yu R; Matthews BJ; Beavis AL
Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
[TBL] [Abstract][Full Text] [Related]
64. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
[TBL] [Abstract][Full Text] [Related]
65. Within-patient comparison between [
Mahieu R; Donders DNV; Krijger GC; Ververs FFT; de Roos R; Bemelmans JLMM; van Rooij R; de Bree R; de Keizer B
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2023-2036. PubMed ID: 34962582
[TBL] [Abstract][Full Text] [Related]
66. [Carbon nanoparticle tracing of sentinel lymph nodes in diagnosis and treatment of cervical cancer and clinical value of lymph node ultrastaging detection].
Lin X; He J; Lu J; Huang C; Liu N
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1896-1901. PubMed ID: 36651260
[TBL] [Abstract][Full Text] [Related]
67. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract][Full Text] [Related]
68. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
Persson J; Salehi S; Bollino M; Lönnerfors C; Falconer H; Geppert B
Eur J Cancer; 2019 Jul; 116():77-85. PubMed ID: 31181536
[TBL] [Abstract][Full Text] [Related]
69. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
70. Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer.
Aoki Y; Kanao H; Fusegi A; Omi M; Okamoto S; Tanigawa T; Nomura H; Omatsu K; Tonooka A
Int J Clin Oncol; 2022 Sep; 27(9):1499-1506. PubMed ID: 35705758
[TBL] [Abstract][Full Text] [Related]
71. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
72. Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green.
Thomaier L; Jager L; Stone R; Wethington S; Fader A; Tanner EJ
Int J Gynecol Cancer; 2019 Mar; 29(3):513-517. PubMed ID: 30833439
[TBL] [Abstract][Full Text] [Related]
73. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
74. Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer.
Dioun S; Chen L; Melamed A; Gockley A; St Clair CM; Hou JY; Khoury-Collado F; Hershman DL; Wright JD
BJOG; 2022 Aug; 129(9):1591-1599. PubMed ID: 34962708
[TBL] [Abstract][Full Text] [Related]
75. Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods.
Sawicki S; Lass P; Wydra D
Int J Gynecol Cancer; 2015 Jul; 25(6):1044-50. PubMed ID: 25853384
[TBL] [Abstract][Full Text] [Related]
76. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
[TBL] [Abstract][Full Text] [Related]
77. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
78. A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer.
Yamagami W; Susumu N; Kataoka F; Makabe T; Sakai K; Ninomiya T; Wada M; Nomura H; Hirasawa A; Banno K; Nakahara T; Kameyama K; Aoki D
Int J Gynecol Cancer; 2017 Sep; 27(7):1517-1524. PubMed ID: 28562470
[TBL] [Abstract][Full Text] [Related]
79. Aortic sentinel node detection in endometrial cancer: 6 year prospective study.
Gorostidi M; Ruiz R; Cespedes J; Jaunarena I; Cobas P; Lekuona A; Diez-Itza I
J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102584. PubMed ID: 37030506
[TBL] [Abstract][Full Text] [Related]
80. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
